CAS: 1345847-93-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Altiratinib REF: IN-DA009CGSCAS: 1345847-93-9 | 98% | 75.00 €~586.00 € | Fri 10 Jan 25 |
 | Altiratinib REF: TM-T2054CAS: 1345847-93-9 | 98.98% - 99.39% | 52.00 €~313.00 € | Fri 17 Jan 25 |
 | Altiratinib REF: 3D-FA137645CAS: 1345847-93-9 | Min. 95% | To inquire | Fri 21 Feb 25 |
Altiratinib
CAS:1345847-93-9
Formula:
C26H21F3N4O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
510.4645
Ref: IN-DA009CGS
| 2mg | 75.00 € | ||
| 5mg | 110.00 € | ||
| 10mg | 135.00 € | ||
| 25mg | 146.00 € | ||
| 50mg | 216.00 € | ||
| 100mg | 486.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Altiratinib
CAS:1345847-93-9
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block …
Formula:
C26H21F3N4O4
Purity:
98.98% - 99.39%
Color and Shape:
Solid
Molecular weight:
510.46
- Inhibitors
- Tyrosine Kinase/Adaptors
- Trk receptor
- VEGFR
- See more categories
- c-Met/HGFR
Ref: TM-T2054
| 5mg | 52.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 135.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 313.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
Altiratinib
CAS:1345847-93-9
Inhibitor of MET, TIE2 and VEGFR2 kinases
Formula:
C26H21F3N4O4
Purity:
Min. 95%
Molecular weight:
510.46 g/mol
Ref: 3D-FA137645
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 21 Feb 2025
